Vertaling van "famhp’s marketing authorisation department is responsible for evaluating " (Nederlands → Frans) :

The FAMHP’s Marketing authorisation Department is responsible for evaluating new applications and requests for amendments to existing marketing authorisation (MA) with a view to granting authorisation for marketing a medicine or health product.
The FAMHP’s Marketing authorisation Department is responsible for evaluating new applications and requests for amendments to existing marketing authorisation (MA) with a view to granting authorisation for marketing a medicine or health product.

The Registration (marketing authorisation) department of the FAMHP is responsible for evaluating new applications and applications for changes to existing marketing authorisations (variations), with a view to grant the authorisation for marketing a medicine or health product.
The Registration (marketing authorisation) department of the FAMHP is responsible for evaluating new applications and applications for changes to existing marketing authorisations (variations), with a view to grant the authorisation for marketing a medicine or health product.

The Registration (marketing authorisation) department for its part is required to evaluate applications for a marketing authorisation (MA), for the sake of the National Procedure (NP), the European Decentralised Procedure (DCP), the Mutual Recognition Procedure (MRP) and the Central Procedure (CP).
The Registration (marketing authorisation) department for its part is required to evaluate applications for a marketing authorisation (MA), for the sake of the National Procedure (NP), the European Decentralised Procedure (DCP), the Mutual Recognition Procedure (MRP) and the Central Procedure (CP).

Transition and backlog In the first phase of the transition to a new structure for the FAMHP, the emphasis is on the reorganisation and restructuring of the Registration (marketing authorisation) department.
Transition and backlog In the first phase of the transition to a new structure for the FAMHP, the emphasis is on the reorganisation and restructuring of the Registration (marketing authorisation) department.

The Production & Distribution department of the FAMHP is responsible firstly for overseeing the conformity to current standards, guidelines and legal requirements for the manufacture, distribution and dispensing of medicines and health products and secondly for granting authorisations, recognitions and certificates, as well as for combating illegal practices and monitoring pharmacies.
The Production & Distribution department of the FAMHP is responsible firstly for overseeing the conformity to current standards, guidelines and legal requirements for the manufacture, distribution and dispensing of medicines and health products and secondly for granting authorisations, recognitions and certificates, as well as for combating illegal practices and monitoring pharmacies.

The R&D (research and development) department of the FAMHP is responsible for the evaluation and approval of clinical research activities, ranging from the first “use” (concept) to extensive trials with medicines that are developed and carried out by university and other research centres and by the pharmaceutical industry.
The R&D (research and development) department of the FAMHP is responsible for the evaluation and approval of clinical research activities, ranging from the first “use” (concept) to extensive trials with medicines that are developed and carried out by university and other research centres and by the pharmaceutical industry.